Cargando…
Long non-coding RNAs regulate drug resistance in cancer
Chemoresistance, whether intrinsic or acquired, is a major obstacle in the treatment of cancer. The resistance of cancer cells to chemotherapeutic drugs can result from various mechanisms. Over the last decade, it has been reported that 1ong noncoding RNAs (lncRNAs) can mediate carcinogenesis and dr...
Autores principales: | Liu, Kaisheng, Gao, Lin, Ma, Xiaoshi, Huang, Juan-Juan, Chen, Juan, Zeng, Leli, Ashby, Charles R., Zou, Chang, Chen, Zhe-Sheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7066752/ https://www.ncbi.nlm.nih.gov/pubmed/32164712 http://dx.doi.org/10.1186/s12943-020-01162-0 |
Ejemplares similares
-
Long non-coding RNAs in anti-cancer drug resistance
por: Chen, Qin-nan, et al.
Publicado: (2016) -
Epitranscriptomics and epiproteomics in cancer drug resistance: therapeutic implications
por: Song, Huibin, et al.
Publicado: (2020) -
Long Non-Coding RNAs in Drug Resistance of Breast Cancer
por: Du, Tonghua, et al.
Publicado: (2020) -
Long non-coding RNAs: From disease code to drug role
por: Chen, Yuanyuan, et al.
Publicado: (2021) -
Sapitinib Reverses Anticancer Drug Resistance in Colon Cancer Cells Overexpressing the ABCB1 Transporter
por: Gao, Hai-Ling, et al.
Publicado: (2020)